Risks include infection, bleeding, changes in speech or swallowing, and potential impact on surrounding structures. Our team takes measures to minimize these risks and ensure a successful outcome.

The TB GOLD Test is an advanced diagnostic tool that uses an interferon-gamma release assay (IGRA) to detect latent tuberculosis infection.

Unlike the tuberculin skin test (TST), the TB GOLD Test does not require a return visit for reading and provides more accurate results by measuring the immune response to TB-specific antigens.

No special preparation is required. You can eat and drink normally before the test, but inform your healthcare provider about any medications or recent illnesses.

Results are typically available within 2 to 7 days after the sample is analyzed in the laboratory.

The TB GOLD Test helps accurately diagnose latent TB infection, which is crucial for preventing the progression to active TB and ensuring appropriate treatment and management.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.